| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/04/2009 | CN101357132A Composition for treating hyperlipemia |
| 02/04/2009 | CN101357131A Composition for treating hyperlipemia |
| 02/04/2009 | CN101357130A Oral microparticles containing pseudoephedrine hydrochloride and cetirizine hydrochloride |
| 02/04/2009 | CN101357129A Medicine composition containing silymarin and kurainone or matrine and use thereof |
| 02/04/2009 | CN101357128A Medicine composition for treating breast cancer |
| 02/04/2009 | CN101357127A Use of carthamus tinctorius yellow colour in preparing medicine for treating and/or preventing myocardial apoptosis |
| 02/04/2009 | CN101357126A Stable taxone albumin lipid drug-loading system and preparation method thereof |
| 02/04/2009 | CN101357125A Use of leonurine in preparing medicine for preventing and treating ischemic cardiomyopathy |
| 02/04/2009 | CN101357124A Medicine for treating osteoarthritis |
| 02/04/2009 | CN101357123A New antivirus, antibacterial method for animal and plant and product thereof |
| 02/04/2009 | CN101357122A Use of carbon monoxide released substance in preparing medicine for treating pyemia |
| 02/04/2009 | CN101357121A Preparation of arilin slow-release medicine-membrane for tooth |
| 02/04/2009 | CN101357119A Medicine microemulsion injection composition and preparation method thereof |
| 02/04/2009 | CN101357118A Medicine composition containing 15 kinds of amino acid and preparation method thereof |
| 02/04/2009 | CN101357117A Breviscapini injection and preparation method thereof |
| 02/04/2009 | CN101357116A Transdermal and transmucosal local narcotic analgesic and preparation method of gel formulation thereof |
| 02/04/2009 | CN100457879C Process for preparing vegetable oil fractions rich in non-tocolic high-melting, unsaponifiable matter |
| 02/04/2009 | CN100457772C Ganoderma lucidum sterol extract and its preparation process and application |
| 02/04/2009 | CN100457767C Flavanone glycoside and its preparation and use |
| 02/04/2009 | CN100457766C non-natural activity dextran tetra saccharide alkyl glycoside composition and its preparation process and application |
| 02/04/2009 | CN100457758C Thienopyrrolizine derivative, its preparing method and pharmaceutical composition containing the same |
| 02/04/2009 | CN100457757C Novel spiro compounds |
| 02/04/2009 | CN100457756C Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands |
| 02/04/2009 | CN100457754C Substituted indolepyridinium as anti-infective compounds |
| 02/04/2009 | CN100457753C N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 02/04/2009 | CN100457752C Pyridine derivatives useful for inhibiting sodium/calcium exchange system |
| 02/04/2009 | CN100457748C Novel phenolic acid compounds of tanshin polyphenolic acid N and application thereof |
| 02/04/2009 | CN100457746C Method for the preparation of escitalopram |
| 02/04/2009 | CN100457742C Biaryl heterocyclic compounds and methods of making and using the same |
| 02/04/2009 | CN100457738C Aryloxyphenyl and arylsulfanylphenyl piperazine derivatives |
| 02/04/2009 | CN100457737C Quinolyl amide derivative and its preparation process and use |
| 02/04/2009 | CN100457735C Therapeutic agents useful for treating pain |
| 02/04/2009 | CN100457732C Method for preparing ropinirole |
| 02/04/2009 | CN100457731C Benzamide modulators of metabotropic glutamate receptors |
| 02/04/2009 | CN100457730C Indoles having anti-diabetic activity |
| 02/04/2009 | CN100457728C Tyrosine kinase inhibitors |
| 02/04/2009 | CN100457726C Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes |
| 02/04/2009 | CN100457720C 2-propyl valeramide and 2-propyl pentaenuylamide derivative and application used as anti-convulsion medicine |
| 02/04/2009 | CN100457719C Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 02/04/2009 | CN100457192C Biotin-derivatives and their conjugates with chelating agents |
| 02/04/2009 | CN100457190C Promoters exhibiting endothelial cell specificity and methods of using same |
| 02/04/2009 | CN100457189C Fusions of cytokines and tumor targeting proteins |
| 02/04/2009 | CN100457184C Multi-stage oral drug controlled-release system |
| 02/04/2009 | CN100457183C Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination |
| 02/04/2009 | CN100457182C Behavior chemotherapy |
| 02/04/2009 | CN100457155C Medicine for treating burn and scald |
| 02/04/2009 | CN100457153C Medicine preparation for treating acne, and its preparation method |
| 02/04/2009 | CN100457150C Capsule or tablet for relieving vision fatigue and preparing method |
| 02/04/2009 | CN100457144C Compound capsule of Chinese date kernel, and preparation method |
| 02/04/2009 | CN100457141C Lipid-lowering cassia capsule and its preparing method |
| 02/04/2009 | CN100457140C Pharmaceutical composition containing lamivudine |
| 02/04/2009 | CN100457128C Drop pills for treating coronary heart disease, angina pectoris and preparation method thereof |
| 02/04/2009 | CN100457127C Medicinal herb solvent extract for treating hepatic disease |
| 02/04/2009 | CN100457124C Therapeutic agents |
| 02/04/2009 | CN100457122C Medicine containing trivalent chromium ions for prevention and/or treatment of amyloidosis |
| 02/04/2009 | CN100457119C Freeze dried ginseng polysaccharide powder for injection and its preparing process |
| 02/04/2009 | CN100457118C 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections |
| 02/04/2009 | CN100457117C Application of woodruff acid with acetyl being removed in preparing medicine for treating rheumatoid arthritis |
| 02/04/2009 | CN100457116C Cercopithecoidealin with anti-tumor function, its preparation and use |
| 02/04/2009 | CN100457115C Blood flow modifier and thrombus prophylactic agent or medicines |
| 02/04/2009 | CN100457114C Use of 1,6-fructo strontium biphosphate for pharmaceuticals |
| 02/04/2009 | CN100457113C Preparation method of bacteriostatic agent sulfadiazine cerium |
| 02/04/2009 | CN100457112C Combination of medication of containing kurarinone and glycyrrhetic acid, and application |
| 02/04/2009 | CN100457111C Pharmaceutical uses of staurosporine derivatives |
| 02/04/2009 | CN100457110C Stable medical freeze dried preparation of tetraodotoxin |
| 02/04/2009 | CN100457109C Stammering treating medicine and its preparing method |
| 02/04/2009 | CN100457108C Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| 02/04/2009 | CN100457107C Pharmaceutical preparation containing the active substance taken as heroin and its utilization in a method for treating opiate addiction |
| 02/04/2009 | CN100457106C Use of 1-deoxynojirimycin for preparing diabete and disney disease drug |
| 02/04/2009 | CN100457105C Bulley aconitne transdermal paster |
| 02/04/2009 | CN100457104C Alkaline salts of proton pump inhibitors |
| 02/04/2009 | CN100457103C Double layer osmotic pump controlled release felodipine medicine composition |
| 02/04/2009 | CN100457102C Pharmaceutical compositions |
| 02/04/2009 | CN100457101C Propylgallate injection with favorable solubility and its preparation process |
| 02/04/2009 | CN100457100C Metoclopramide orally disintegrating tablet and its production method |
| 02/04/2009 | CN100457099C Hemorrhoid injection |
| 02/04/2009 | CN100457098C Freeze-dried powder injection of nafamostat mesylate and its preparing method |
| 02/04/2009 | CN100457097C Composition for lowering blood glucose |
| 02/04/2009 | CN100457096C An elemene formulation and preparation method thereof |
| 02/04/2009 | CN100457095C Improved transdermal therapeutic system for treatment of Parkinson's disease |
| 02/04/2009 | CN100457094C Preparing process of biodegradable capsule loading medicine and nano magnetic particle |
| 02/04/2009 | CN100457087C Stable pharmaceutical solution formulation for pressurized metered dose inhalers |
| 02/04/2009 | CN100457078C Cosmetics |
| 02/04/2009 | CN100457076C Application of paeonol in preparation of whitening and freckle-removing cosmetic or pigmentation disease-treating medicine for inhibiting generation and transmission of melanin |
| 02/04/2009 | CN100457063C Active intrauterine contraceptive device made of composite material |
| 02/04/2009 | CN100456962C Food product comprising soy protein and statins |
| 02/04/2009 | CN100456946C Oilseed processing |
| 02/04/2009 | CN100456932C Stable, low free formaldehyde, synergistic antimicrobial compositions of aldehyde donors and dehydroacetic acid |
| 02/04/2009 | CN100456924C Systematized disinfecting method for nucleus-insertion technique of nucleated pearl |
| 02/03/2009 | US7485755 Acid addition salt of carbasugar amine derivative |
| 02/03/2009 | US7485753 Cyclopropane scaffolding moiety having three iodinated phenyl groups bound thereto; less renal toxicity, improved viscosity, iodine concentration and solubility |
| 02/03/2009 | US7485752 Diacylglycerol acyltransferase inhibitors |
| 02/03/2009 | US7485750 novel compound showing antioxidant effects,collagen biosynthesis ability and skin pore contraction effects without showing instability; for preventing skin aging; N-(4-((hydroxycarbamoyl)methyl)phenyl)-3,4-dibutoxy benzamide |
| 02/03/2009 | US7485743 Oligomeric ketone compounds |
| 02/03/2009 | US7485732 Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 02/03/2009 | US7485730 Pharmaceutical compounds |
| 02/03/2009 | US7485724 2,4-pyrimidinediamine compounds and their uses |
| 02/03/2009 | US7485720 spherical cellulose material comprising a water-insoluble polysaccharide formed by beta -1,4-type sugar chain linkages, the degree of crystallinity is 70% or greater, and macrofibrils are formed radially from the center to the periphery; produced by Enterobacter; easily separated from the culture broth |
| 02/03/2009 | US7485719 Forms crosslinked product through covalent bond between active ester group in side chain and active hydrogen-containing group selected from a hydroxy group, an amino group, and a thiol group upon contact with alkaline water; biodegradable, nontoxic, bioabsorbable; low risk of infection; medical equipment |
| 02/03/2009 | US7485713 Polypeptides comprising growth hormone receptor extracellular domain and glycosylphosphatidylinositol |